Risk factors associated with ventricular fibrillation during first ST-elevation myocardial infarction: Individual participant data analysis of 3 prospective case-control studies.

Heart Rhythm

Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark; Member of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart; Department of Forensic Medicine, Faculty of Medical Science, University of Copenhagen, Denmark.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Most of sudden cardiac death in the adult population is caused by ventricular fibrillation (VF) in the setting of acute myocardial ischemia. The assessment of risk factors for VF in this setting may point to novel causal pathways or new targets for intervention and risk prediction of sudden cardiac death.

Objective: This study aimed to evaluate the effect of family history of sudden death (SD), history of atrial fibrillation (AF), and anterior infarct location on the electrocardiogram on the development of VF during the first ST-elevation myocardial infarction (STEMI).

Methods: We performed an individual participant data meta-analysis of 3 European case-control studies including patients with a first STEMI (aged 18-80 years) with VF (cases) or without VF (controls) before revascularization.

Results: We included 1807 cases and 2923 controls (median age 59 years, 20% women) in the analyses. After adjusting for potential confounding, we found an independent association between the 3 risk factors and VF: family history of SD (odds ratio [OR] 1.61, 95% confidence interval 1.38-1.87), previous AF (OR 1.95, 1.22-3.11), and anterior myocardial infarction (OR 1.55, 1.36-1.75). Further investigation indicated increased effect of family history with multiple SDs in the family, a stronger effect of AF on VF developing within the first minutes of symptoms, and the effect of anterior infarctions being modified by enzymatically determined infarct size.

Conclusion: Family history of SD, history of AF, and anterior infarct location were all independently and additively associated with an increased risk of VF in patients with a first STEMI.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hrthm.2025.06.026DOI Listing

Publication Analysis

Top Keywords

family history
16
risk factors
12
myocardial infarction
12
ventricular fibrillation
8
st-elevation myocardial
8
individual participant
8
participant data
8
case-control studies
8
sudden cardiac
8
anterior infarct
8

Similar Publications

Expression analysis of C-FOS and XRCC3 Thr241Met polymorphism in gastric cancer.

Cell Mol Biol (Noisy-le-grand)

September 2025

Department of Biology, College of Education for Pure Sciences, University of Kerbala, Kerbala, Iraq.

Gastric cancer is one of the causes of deaths related to cancer across the globe and both genetic and environmental factors are the most prominent. Causes of its pathogenesis. This paper researches the expression of the C-FOS gene.

View Article and Find Full Text PDF

A 52-year-old Myanmar man presented with bilateral progressive painless asymmetrical wrist and finger drop in 1 year without any sensory and sphincter problems. He has hypochromic microcytic anemia diagnosed as Hemoglobin E disease before. However, a serial full blood count revealed thrombocytopenia and a drop in hemoglobin disproportionate to HbE disease.

View Article and Find Full Text PDF

Lead poisoning is rare, but easily missed, with the highest burden of disease occurring in low-to-middle income countries. However, when diagnosed, appropriate treatment can prevent long-term morbidity. A case is presented, reinforcing the importance of thorough history-taking and international guidelines in successful treatment.

View Article and Find Full Text PDF

Factor XIII (FXIII) deficiency is a rare coagulopathy with an estimated prevalence of approximately 1 in 1 to 2 million, affecting males and females with equal frequency. FXIII plays a critical role in hemostasis by stabilizing fibrin clots through covalent cross-linking of fibrin monomers, thereby conferring mechanical resistance and durability to the clot structure. Clinically, FXIII deficiency presents with a spectrum of hemorrhagic manifestations including bleeding from the umbilical cord, intracranial hemorrhage, recurrent miscarriages, menorrhagia, epistaxis, gingival bleeding, and poor wound healing.

View Article and Find Full Text PDF

Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report.

Case Rep Hematol

August 2025

Department of Internal Medicine, Skagit Regional Health, Mount Vernon, Washington, USA.

Waldenström macroglobulinemia (WM) and essential thrombocythemia (ET) are distinct hematologic malignancies that have only been reported to co-occur in one previous patient. We present a 64-year-old man with a significant family history for WM who was found to have both ET and WM. He had symptomatic ET, diagnosed by elevated platelets and a positive JAK2 V617F mutation, and asymptomatic WM was found on serum electrophoresis done for screening due to family history.

View Article and Find Full Text PDF